GO@Fe3O4@CuSilicate Composite with a Hierarchical Structure: Fabrication, Microstructure, and Highly Electromagnetic Shielding Performance

AgNWs/Fe3O4@NC Conductive Network Hierarchical Assembly to Prepare Flexible EMI Shielding Textile

With the rapid development of high-power electronic instruments and communication technology, efficient electromagnetic shielding materials with strong absorption of electromagnetic waves and low reflection characteristics have become the focus of the world's attention. This study designs and synthesizes N-doped carbon-coated hollow Fe3O4 nanospheres (Fe3O4@NC) by spraying Ag nanowires (AgNWs) on textiles as conductive networks. Because of the high permeability and hollow structure Fe3O4@NC, electromagnetic wave goes through a unique process of "absorption, reflection, and reabsorption" when it passes through the surface of the composite textile. In X-band (≈8.2-12.4 GHz), the average electromagnetic interference shielding effectiveness (EMI SE) reaches 50.1 dB, while the reflectance shielding efficiency (SER) is only 2.6 dB, and the average reflectance power coefficient (R) is as low as 0.45. The composite fabric has excellent properties and provides an effective strategy for electromagnetic interference shielding based on absorption.

Engineering of gemcitabine coated nano-graphene oxide sheets for efficient near-infrared radiation mediated in vivo lung cancer photothermal therapy

Gemcitabine (GEM) and its derivatives of deoxycytosine is a promising anticancer candidate which is effective for the treatment of various cancers including lung cancer via cascade targetting Erk/Mek/Raf/Ras pathway and blocking the proliferation of the tumor cells. In this present work, we have described reduced graphene oxide (rGO) in the presence of anticancer utilizing ascorbic acid as reducing agents for lung cancer treatment. GEM reduced graphene oxide (termed as GEM-rGO) has resulted in a smooth and transparent morphological surface, which was confirmed by various spectroscopical investigations. The anticancer drug-loaded rGO has displayed remarkable cytotoxic activities against a panel of lung cancer cell lines when compared to the untreated lung cancer cells. Further, we examined the morphological observation of the cancer cell death was monitored through the fluorescence microscopic examinations. In addition, the cell deaths of the lung cancer cells were observed by the flow cytometry analyses. In addition, the non-toxic nature of potent GEM-rGO and GEM-rGO + NIR was confirmed by in vivo systemic toxicity analysis. Besides, the higher safety feature of the GEM-rGO and GEM-rGO + NIR was evidenced by histological analyses of the mice organs. The subcutaneous injection of GEM-rGO and GEM-rGO + NIR into mice bearing A549 xenografts more effectively inhibited the tumor than the free GEM. Based on the outcomes, we can summarise that the GEM reduced graphene oxide (GEM-rGO) can be used as a promising drug candidate for the treatment of lung cancer in the future.